Back to News
May 14, 2026 8:10 AM

BIOREM Reports First Quarter Financial Results and Record $77 Million Order Backlog, Revenue Increase of 44%

GUELPH, ON, May 14, 2026 /CNW/ - BIOREM Inc. (TSXV:BRM) ("BIOREM" or "the Company") today announced results for the three month period ended March 31, 2026.  BIOREM's complete 2026 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com).

Financial Summary:

Three-months

March 31

Ended

December 31

(in CDN$'000 except per share data)

2026

2025

2025

Revenue

6,817

4,730

16,941

Gross profit

1,392

1,110

5,942

Operating expenses

1,084

1,016

2,212

Ebitda*

399

229

3,823